FDA and Abbot Reach Deal to Produce Formula in Michigan Amid Shortage

STURGIS, MICHIGAN, May 17, 2022 ~ The FDA and Abbott Nutrition have reached a deal to reopen an infant-formula-manufacturing plant in Sturgis, Michigan, though production is still months away.

The plant was shut down nearly four months ago by the FDA after four bacterial infections in infants were linked to the facility, two of whom reportedly died. Abbott has denied the link, saying the strains of bacteria did not match those found inside their plant.

“Our number one priority is getting infants and families the high-quality formulas they need, and this is a major step toward re-opening our Sturgis facility so we can ease the nationwide formula shortage,” said Abbott CEO Robert B. Ford in a statement. 

“We know millions of parents and caregivers depend on us and we’re deeply sorry that our voluntary recall worsened the nationwide formula shortage.”

Listen below, as 760 WJR Senior News Analyst Marie Osborne brings you the latest on the shortage, with a look at when relief for families might be available.